Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (21-30 of 246) with videos related to

Pageof 25
Sort By:
Rheumatology Advances in Practice|June 14, 2021
Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilizationDiego Benavent, Luis Fernández-Luque, Victoria Navarro-Compán, et al.
Therapeutic Drug Monitoring|April 6, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in SpondyloarthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
JBMR Plus|October 25, 2024
Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic <i>ALPL</i> studyCarolina Tornero, Eugenio de Miguel, Victoria Navarro-Compán, et al.
Therapeutic Drug Monitoring|July 13, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid ArthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Reumatologia Clinica|March 12, 2017
Septic arthritis in a native knee due to Corynebacterium striatumJuan Molina Collada, Alicia Rico Nieto, Macarena Díaz de Bustamante Ussia, et al.
Rheumatology (Oxford, England)|January 25, 2018
Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON studyAlejandro Balsa, Raimon Sanmarti, José Rosas, et al.
The Journal of Rheumatology|January 6, 2004
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritisAlejandro Balsa, Loreto Carmona, Isidoro González-Alvaro, et al.
The Journal of Rheumatology|April 3, 2003
Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritisIsidoro Gonzalez-Alvaro, Loreto Carmona, Alejandro Balsa, et al.
Rheumatology and Therapy|November 1, 2019
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic InterventionsJosé A Sacristán, Silvia Díaz, Inmaculada de la Torre, et al.
Pageof 25

Showing results (21-30 of 246) with videos related to

Sort By:
Pageof 25
Rheumatology Advances in Practice|June 14, 2021
Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilizationDiego Benavent, Luis Fernández-Luque, Victoria Navarro-Compán, et al.
Therapeutic Drug Monitoring|April 6, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in SpondyloarthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
JBMR Plus|October 25, 2024
Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic <i>ALPL</i> studyCarolina Tornero, Eugenio de Miguel, Victoria Navarro-Compán, et al.
Therapeutic Drug Monitoring|July 13, 2017
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid ArthritisFrédéric Medina, Chamaida Plasencia, Philippe Goupille, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Reumatologia Clinica|March 12, 2017
Septic arthritis in a native knee due to Corynebacterium striatumJuan Molina Collada, Alicia Rico Nieto, Macarena Díaz de Bustamante Ussia, et al.
Rheumatology (Oxford, England)|January 25, 2018
Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON studyAlejandro Balsa, Raimon Sanmarti, José Rosas, et al.
The Journal of Rheumatology|January 6, 2004
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritisAlejandro Balsa, Loreto Carmona, Isidoro González-Alvaro, et al.
The Journal of Rheumatology|April 3, 2003
Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritisIsidoro Gonzalez-Alvaro, Loreto Carmona, Alejandro Balsa, et al.
Rheumatology and Therapy|November 1, 2019
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic InterventionsJosé A Sacristán, Silvia Díaz, Inmaculada de la Torre, et al.
Pageof 25